Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): Report of 11 cases treated with pefloxacin

Archives of Dermatology

Volumn 143, Issue 8, 2007, Pages 1046-1050

  Asli, Bouchra ^a   Bienvenu, Boris ^b   Cordoliani, Florence ^a   Brouet, Jean Claude ^a   Uzunhan, Yurdagul ^c   Arnulf, Bertrand ^a   Malphettes, Marion ^a   Rybojad, Michel ^a   Fermand, Jean Paul ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Hôpital Cochin ^*  (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETAMETHASONE ACETATE; BISPHOSPHONIC ACID DERIVATIVE; CHLORAMBUCIL; CHLOROQUINE; COLCHICINE; CYCLOPHOSPHAMIDE; DAPSONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN M; NONSTEROID ANTIINFLAMMATORY AGENT; PEFLOXACIN MESILATE; PREDNISONE; PSORALEN; TECHNETIUM 99M; THALIDOMIDE;

ACHILLES TENDINITIS; ADULT; AGED; ARTHRALGIA; ARTICLE; BONE PAIN; CHRONIC URTICARIA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIARRHEA; DRUG DOSE REDUCTION; DRUG SAFETY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; IMPOTENCE; INSOMNIA; MONOCLONAL IMMUNOGLOBULINEMIA; MYALGIA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; SCHNITZLER SYNDROME; SCINTISCANNING; SKIN BIOPSY; TREATMENT DURATION; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; PEFLOXACIN; RETROSPECTIVE STUDIES; SCHNITZLER SYNDROME; TREATMENT OUTCOME;

EID: 34548099010     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.8.1046     Document Type: Article

References (16)

1. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome: four new cases and review of the literature. Medicine (Baltimore). 2001;80(1):37-44.
2. de Castro FR, Masouye I, Winkelmann RK, Saurat JH. Urticarial pathology in Schnitzler's (hyper-IgM) syndrome. Dermatology. 1996;193(2):94-99.
3. de Koning HD, Bodar EJ, Simon A, van der Hilst JC, Netea MG, van der Meer JW. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis. 2006;65(4):542-544.
4. Goupille P, Pizzuti P, Diot E, Jattiot F, Guilmot JL, Valat JP. Schnitzler's syndrome (urticaria and macroglobulinemia) dramatically improved with corticosteroids. Clin Exp Rheumatol. 1995;13(1):95-98.
5. Clauvel JP, Brouet JC, Danon F, Leibowitch M, Seligmann M. Chronic urticaria with monoclonal IgM: a report of five cases. Clin Immunol Immunopathol. 1982;25(3):348-353.
6. Treon SP, Gertz MA, Dimopoulos M, et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia. Blood. 2006;107(9):3442-3446.
7. Worm M, Kolde G. Schnitzler's syndrome: successful treatment of two patients using thalidomide. Br J Dermatol. 2003;148(3):601-602.
8. Schartz NE, Buder S, Sperl H, et al. Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b. Dermatology. 2002;205(1):54-56.
9. Pascual-López M, Hernandez-Nunez A, Sanchez-Perez J, Fernandez-Herrera J, Garcia-Diez A. Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin. J Eur Acad Dermatol Venereol. 2002;16(3):267-270.
10. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003;36(11):1404-1410.
11. Lipsker D, Spehner D, Drillien R, et al. Schnitzler's syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol. 2000;142(5):954-959.
12. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L. Anti-interleukin-1 autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition-higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol. 1991;88(2):244-256.
13. Morita A, Sakakibara S, Yokota M, Tsuji T. A case of urticarial vasculitis associated with macroglobulinemia (Schnitzler's syndrome). J Dermatol. 1995;22(1):32-35.
14. Hooper DC. Quinolone mode of action-new aspects. Drugs. 1993;45(suppl 3):8-14.
15. Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis. 2003;3(6):359-371.
16. Stover DE, Mangino D. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia? Chest. 2005;128(5):3611-3617.